Increased Prevalence of Psychopathology and Maladaptive Personality Traits after Long-Term Cure of Cushing’s Disease
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Psychopathology and maladaptive personality traits are often observed during the active phase of Cushing's disease (CD). We hypothesized that patients with long-term cure of CD show persistent psychopathology and maladaptive personality traits. DESIGN: Four questionnaires on frequently occurring psychopathology in somatic illnesses were used, including the Apathy Scale, Irritability Scale, Hospital Anxiety and Depression Scale, and Mood and Anxiety Symptoms Questionnaire short-form. Personality was assessed using the Dimensional Assessment of Personality Pathology short-form (DAPPs). PATIENTS AND CONTROL SUBJECTS: We included 51 patients cured of CD (16% men, 53 ± 13 yr) and 51 matched controls. In addition, we included 55 patients treated for nonfunctioning pituitary macroadenomas (55% men, 62 ± 10 yr), and 55 matched controls. RESULTS: Mean duration of remission was 11 yr (range 1-32 yr). Compared with matched controls, patients cured from CD scored significantly worse on virtually all questionnaires. Compared with nonfunctioning pituitary macroadenoma patients, patients treated for CD scored worse on apathy (P < 0.001), irritability (P < 0.001), anxiety (P < 0.001), negative affect and lack of positive affect (P < 0.001 on both scales), somatic arousal (P < 0.001), and 11 of 18 subscales of the Dimensional Assessment of Personality Pathology short-form (P < 0.05). CONCLUSIONS: Patients with long-term cured CD show an increased prevalence of psychopathology and maladaptive personality traits. These observations suggest irreversible effects of previous glucocorticoid excess on the central nervous system rather than an effect of pituitary tumors and/or their treatment in general. This may also be of relevance for patients treated with high doses of exogenous glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [150]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications
Clark, L. A., & Watson, D. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.3.316 · Cited by 4,601 · cited 1×
“There are no formal cutoff scores (15).”
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 1×
“A score greater than 8 points on one of the subscales is being used to characterize subjects as being anxious or depressed respectively (13, 14).”
MethodSyndromic Validity of Apathy in Alzheimer’s Disease
Starkstein, S. E., Petracca, G., Chemerinski, E., & Kremer, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.872 · Cited by 392 · cited 2×
“A total score of 14 points or more is being used to characterize subjects as apathetic (11, 12).”
BackgroundStarkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289 · cited 1×
“Psychopathology is reported to be present in the majority of patients with active Cushing’s disease (17).”
BackgroundSonino, N., & Fava, G. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00003 · Cited by 267 · cited 5×
“019] remained significantly different between patients and controls, whereas the traits identity problems [F (1) 3.”
BackgroundMethodInfluentialDorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 2×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundResultQuality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253 · cited 1×
“However, these patients do not completely return to their premorbid level of functioning, and persistently impaired quality of life has been reported despite long-term cure (4).”
BackgroundEffects of Glucocorticoids on Mood, Memory, and the Hippocampus: Treatment and Preventive Therapy
Brown, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04981.x · Cited by 214 · cited 1×
“or exogenous exposure to glucocorticoids may have longlasting adverse effects on behavioral and cognitive functions due to functional and, over time, structural alterations in specific brain target areas (8, 9).”
BackgroundPereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173 · cited 5×
“80 Medium: 13 Medium: 16 High: 18 High: 17 Surgery, n (%) 51 (100%) NA NA Postoperative radiotherapy, n (%) 11 (22%) NA NA Duration of remission (yr) 11 (9) NA NA Duration of follow-up (yr) 14 (10) NA NA Hypopituitarism, n (%) Any axis: 31 (61%) NA NA GH: 20 (39%) LH/FSH: 14 (28%) TSH: 21 (41%) ADH: 10 (20%) Hydrocort…”
BackgroundInfluentialDiagnostic categorization of psychiatric disturbance in Cushing's syndrome
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.8.911 · Cited by 171
Starkman, M. N., SCHTEINGART, D. E., & Schork, M. A. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90096-x · Cited by 163 · cited 1×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundCushing's Syndrome: A Psychiatric Study of 29 Patients
Cohen, S. I. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.2.120 · Cited by 162 · cited 2×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundPsychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features
Dorn, L. D., Burgess, E. S., Dubbert, B., Simpson, S., Friedman, T., Kllng, M., Gold, P. W., & Chrousos, G. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02614.x · Cited by 152 · cited 1×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundMood Changes During Prednisone Bursts in Outpatients With Asthma
Brown, E. S., Suppes, T., Khan, D. A., & Carmody, T. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00009 · Cited by 151 · cited 1×
“Furthermore, the results of the current study may be relevant for patients who have previously been treated with prolonged high doses of glucocorticoids (27, 28).”
BackgroundClinical Correlates of Major Depression in Cushing’s Disease
Sonino, N., Fava, G. A., Raffi, A. R., Boscaro, M., & Fallo, F. (1998) · Psychopathology · doi:10.1159/000029054 · Cited by 150
Mood Symptoms during Corticosteroid Therapy: A Review
Brown, S. E., & Suppes, T. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000307 · Cited by 147 · cited 1×
“Furthermore, the results of the current study may be relevant for patients who have previously been treated with prolonged high doses of glucocorticoids (27, 28).”
BackgroundPsychiatric Phenomenology in Cushing's Disease
Loosen, P., Chambliss, B., DeBold, C., Shelton, R., & Orth, D. (1992) · Pharmacopsychiatry · doi:10.1055/s-2007-1014405 · Cited by 126 · cited 1×
“Several previous studies in patients with active Cushing’s disease concluded that patients had a higher tendency for anxiety than controls (6, 19, 25).”
BackgroundRating depressed patients: observer- vs self-assessment
Möller, H. J. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00229-7 · Cited by 120 · cited 1×
“However, self-reported scales provide a valuable tool to measure the patients’ perception of their illness, which is not possible with observer ratings (26).”
MethodPsychiatric aspects of Cushing's syndrome
Kelly, W. F. (1996) · QJM · doi:10.1093/qjmed/89.7.543 · Cited by 119
A prospective study of psychiatric and psychological aspects of Cushing's syndrome
Kelly, W. F., Kelly, M. J., & Faragher, B. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8690878.x · Cited by 114 · cited 4×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundResultInfluentialCentral nervous system effects of natural and synthetic glucocorticoids
Fietta, P., Fietta, P., & Delsante, G. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02005.x · Cited by 111 · cited 2×
“80 Medium: 13 Medium: 16 High: 18 High: 17 Surgery, n (%) 51 (100%) NA NA Postoperative radiotherapy, n (%) 11 (22%) NA NA Duration of remission (yr) 11 (9) NA NA Duration of follow-up (yr) 14 (10) NA NA Hypopituitarism, n (%) Any axis: 31 (61%) NA NA GH: 20 (39%) LH/FSH: 14 (28%) TSH: 21 (41%) ADH: 10 (20%) Hydrocort…”
BackgroundChatterjee, A. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.3.378 · Cited by 101 · cited 2×
“A total score of 14 points or more is being used to characterize subjects as apathetic (11, 12).”
BackgroundPersonality characteristics and quality of life in patients treated for Cushing's syndrome
Sonino, N., Bonnini, S., Fallo, F., Boscaro, M., & Fava, G. A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02462.x · Cited by 69 · cited 2×
“However, another recent study concluded that were no differences in personality traits between patients with Cushing’s syndrome in remission and controls (7).”
BackgroundResultvan Kampen, D., de Beurs, E., & Andrea, H. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.05.002 · Cited by 58 · cited 1×
“There are no formal cutoff scores (16).”
Flitsch, J., Spitzner, S., & Lüdecke, D. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-8144 · Cited by 56
Psychosocial impairment in patients treated for pituitary disease: a controlled study
Sonino, N., Ruini, C., Navarrini, C., Ottolini, F., Sirri, L., Paoletta, A., Fallo, F., Boscaro, M., & Fava, G. A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02951.x · Cited by 51 · cited 1×
“Several previous studies in patients with active Cushing’s disease concluded that patients had a higher tendency for anxiety than controls (6, 19, 25).”
BackgroundPERSONALITY CHANGES IN CUSHING'S SYNDROME*
STARR, A. M. (1952) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-12-5-502 · Cited by 37
Aspects of personality in patients with pituitary adenomas
Sablowski, N., Pawlik, K., L�decke, D. K., & Herrmann, H. D. (1986) · Acta Neurochirurgica · doi:10.1007/bf01420501 · Cited by 26 · cited 1×
“Several previous studies in patients with active Cushing’s disease concluded that patients had a higher tendency for anxiety than controls (6, 19, 25).”
Background
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Finally, in this guideline, we discuss potential new therapies and future ways to improve quality of life (QOL) for individuals with CAH.”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Dynamics of ACTH and Cortisol Secretion and Implications for Disease
Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa002 · Cited by 439
Cortisol and depression: three questions for psychiatry
Herbert, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712000955 · Cited by 301
“Reexamining recovered Cushing’s patients in the expectation that they return to a basal, pre-morbid state is vitiated by knowledge that recovery is often incomplete and the effects of hypercortisolaemia are prolonged (Pereira et al. 2010 ; Tiemensma et al. 2010).”
BackgroundFeelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Metadata
- Authors
- Tiemensma, J., Biermasz, N. R., Middelkoop, H. A. M., van der Mast, R. C., Romijn, J. A., & Pereira, A. M.
- Affiliations
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- E129-E141
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140913018
- Cited by
- 142
- References
- 29
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 13 · 2012: 15
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, psychopathology, maladaptive personality traits, long-term remission, apathy, irritability, anxiety, negative affect, somatic arousal, glucocorticoid excess, non-functioning pituitary macroadenoma, exogenous glucocorticoids, personality pathology
- MeSH terms
- Adaptation, Psychological, Adenoma, Adult, Aged, Mental Disorders, Female, Humans, Male, Middle Aged, Personality Disorders, Pituitary Neoplasms, Psychiatric Status Rating Scales, Psychopathology, Surveys and Questionnaires, Time Factors, Prevalence, Case-Control Studies, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.